Defender Capital, Llc. Oncocyte Corp Transaction History

Defender Capital, Llc.

  • $239 Million
  • Q1 2025

A detailed history of Defender Capital, Llc. transactions in Oncocyte Corp stock. As of the latest transaction made, Defender Capital, Llc. holds 44,378 shares of OCX stock, worth $149,553. This represents 0.06% of its overall portfolio holdings.

Number of Shares
44,378
Previous 47,078 5.74%
Holding current value
$149,553
Previous $116,000 16.38%
% of portfolio
0.06%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
SELL
$1.96 - $4.58 $5,292 - $12,366
-2,700 Reduced 5.74%
44,378 $135,000
Q4 2024

Jan 23, 2025
SELL
$2.11 - $3.15 $25,900 - $38,666
-12,275 Reduced 20.68%
47,078 $116,000
Q3 2024

Oct 21, 2024
BUY
$2.85 - $3.36 $11,779 - $13,886
4,133 Added 7.48%
59,353 $169,000
Q2 2024

Jul 29, 2024
SELL
$2.44 - $3.07 $1,622 - $2,041
-665 Reduced 1.19%
55,220 $162,000
Q1 2024

May 06, 2024
SELL
$2.84 - $3.6 $44,772 - $56,754
-15,765 Reduced 22.0%
55,885 $163,000
Q4 2023

Jan 23, 2024
SELL
$2.08 - $4.26 $89,169 - $182,626
-42,870 Reduced 37.43%
71,650 $179,000
Q3 2023

Oct 23, 2023
SELL
$0.2 - $4.28 $442,682 - $9.47 Million
-2,213,410 Reduced 95.08%
114,520 $357,000
Q2 2023

Jul 18, 2023
SELL
$0.2 - $0.35 $7,100 - $12,425
-35,500 Reduced 1.5%
2,327,930 $535,000
Q1 2023

Apr 27, 2023
BUY
$0.2 - $0.49 $18,100 - $44,345
90,500 Added 3.98%
2,363,430 $827,000
Q4 2022

May 16, 2023
SELL
$0.25 - $15.6 $22,625 - $1.41 Million
-90,500 Reduced 3.83%
2,272,930 $727,000
Q4 2022

Jan 12, 2023
SELL
$0.25 - $15.6 $69,762 - $4.35 Million
-279,050 Reduced 10.93%
2,272,930 $729,000
Q3 2022

Oct 18, 2022
SELL
$0.76 - $15.98 $28,424 - $597,652
-37,400 Reduced 1.44%
2,551,980 $1.88 Million
Q2 2022

Jul 26, 2022
BUY
$0.86 - $1.53 $23,435 - $41,692
27,250 Added 1.06%
2,589,380 $2.33 Million
Q1 2022

Apr 22, 2022
BUY
$1.15 - $2.25 $397,129 - $776,992
345,330 Added 15.58%
2,562,130 $4 Million
Q4 2021

Feb 01, 2022
BUY
$2.04 - $3.59 $522,199 - $918,968
255,980 Added 13.05%
2,216,800 $4.81 Million
Q3 2021

Nov 01, 2021
BUY
$3.53 - $5.89 $2.17 Million - $3.61 Million
613,620 Added 45.55%
1,960,820 $6.94 Million
Q2 2021

Jul 29, 2021
BUY
$3.77 - $6.0 $2.8 Million - $4.46 Million
742,750 Added 122.88%
1,347,200 $7.73 Million
Q1 2021

Apr 20, 2021
BUY
$2.39 - $6.5 $1.44 Million - $3.93 Million
604,450 New
604,450 $3.12 Million

Others Institutions Holding OCX

# of Institutions
3
Shares Held
396K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $400M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Defender Capital, Llc. Portfolio

Follow Defender Capital, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Defender Capital, Llc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email